AgaMatrix and Glytec said today that the companies are partnering to develop a cloud-based diabetes management platform to optimize clinical access to glucose data and insulin titration support.
The platform will combine AgaMatrix’s FDA-cleared Jazz Wireless 2 Bluetooth blood glucose monitoring tech with Glytec’s eGlycemic Management System, according to the companies.
Get the full story at our sister site, Drug Delivery Business News.
The post Glytec, AgaMatrix ink deal to develop digital diabetes management platform appeared first on MassDevice.